Gi-Deok Eom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gi-Deok Eom has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fu-Shi Quan
Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute (CRI), Kyung Hee University, Seoul 02447, Republic of Korea
3 shared publications - Hae-Ji Kang
Department of Microbiology, College of Medicine, Dongguk University, Gyeongju 38066, Korea
3 shared publications - Jie Mao
Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea
3 shared publications - Keon-Woong Yoon
Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea
3 shared publications - Ki Back Chu
Department of Parasitology, College of Medicine, Inje University, Busan 47392, Republic of Korea
3 shared publications - Eun-Kyung Moon
Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul 02447, Korea
2 shared publications
Latest Publications
- 25 September 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (29) , 2437-2446
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice
Aim: To evaluate the protective efficacy induced by heterologous immunization with recombinant baculoviruses or virus-like particles targeting the CST1 and ROP18 antigens of Toxoplasma gondii.Materials & methods: Recombinant baculovirus and virus-like particle vaccines expressing T. gondii CST1 or ROP18 antigens were developed to evaluate protective immunity in mice upon challenge infection with 450 Toxoplasma gondii (ME49).Results: Immunization with CST1 or ROP18 vaccines induced similar levels of T. gondii-specific IgG and IgA responses. Compared with ROP 18, CST1 vaccine showed better antibody-secreting cell response, germinal center B cell activation, and significantly reduced brain cyst burden and body weight loss.Conclusion: Our findings suggest that CST1 heterologous immunization elicited better protection than ROP18, providing important insight into improving the toxoplasmosis vaccine design strategy.
- 25 September 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (29) , 2437-2446
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice
Aim: To evaluate the protective efficacy induced by heterologous immunization with recombinant baculoviruses or virus-like particles targeting the CST1 and ROP18 antigens of Toxoplasma gondii.Materials & methods: Recombinant baculovirus and virus-like particle vaccines expressing T. gondii CST1 or ROP18 antigens were developed to evaluate protective immunity in mice upon challenge infection with 450 Toxoplasma gondii (ME49).Results: Immunization with CST1 or ROP18 vaccines induced similar levels of T. gondii-specific IgG and IgA responses. Compared with ROP 18, CST1 vaccine showed better antibody-secreting cell response, germinal center B cell activation, and significantly reduced brain cyst burden and body weight loss.Conclusion: Our findings suggest that CST1 heterologous immunization elicited better protection than ROP18, providing important insight into improving the toxoplasmosis vaccine design strategy.
- 23 February 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (9) , 741-754
Crossprotection Induced by Virus-Like Particles Containing Influenza Dual-Hemagglutinin and M2 Ectodomain
Aims: To develop an effective universal vaccine against antigenically different influenza viruses. Materials & methods: We generated influenza virus-like particles (VLPs) expressing the H1 and H3 a... Graphical abstract
- 23 February 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (9) , 741-754
Crossprotection Induced by Virus-Like Particles Containing Influenza Dual-Hemagglutinin and M2 Ectodomain
Aims: To develop an effective universal vaccine against antigenically different influenza viruses. Materials & methods: We generated influenza virus-like particles (VLPs) expressing the H1 and H3 a... Graphical abstract
- Open Access
- 28 November 2023
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 61 (4) , 418-427
The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.
- 28 November 2023
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 61 (4) , 418-427
Open AccessThe detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.